Table 1.
Study outcomes and definitions.
| Study outcome | Analysis denominator | Outcome definition |
|---|---|---|
| Recognition of CKD | Study eligible and no documentation of CKD at index | CKD diagnosis code (ICD10) assigned at an inpatient or outpatient encounter, or the entry of CKD diagnosis on the problem list, from index through 18 months post-index |
| BP control | Study eligible and BP care gap identified at indexa | Most recent systolic BP (SBP) and diastolic BP (DBP) values in the 18 months post-index in the recommended range using office BP measurements |
| ACEI or ARB use | Study eligible and ACEI / ARB use care gap identified at indexa | Prescription for an ACEI or ARB medication in the 18 months post-index |
| Glucose control | Study eligible and glucose care gap identified at indexa | Last A1C value in the 18 months post-index below the A1C goal recommendation |
| Nephrology referral | Study eligible and nephrology visit care gap at indexa | Referral to nephrology (electronic) in the 18 months post-index period. |
Care gaps for the analysis denominators are the same as those defined in the inclusion criteria.